In today’s briefing:
- HK CEO & Director Dealings (28th Feb 2025): Mobvista, Xtep, Onewo, Bonny International
- Tencent (700 HK): Expiry-Day Recap; Intra-Day Swing of 4.1%.
- Asia Real Estate Tracker (28-Feb-2025): HK halts commercial land sales to cure office slump.
- Monthly Container Shipping Tracker | No, Not All Trade Disruptions Boost Carriers (February 2025)
- China Mobile (941 HK) Pullback Offers a Tactical Re-Entry Opportunity
- Lucror Analytics – Morning Views Asia
- BeiGene (6160 HK): Brukinsa Outpaces Competitor in 4Q US Sales; Solid Guidance for 2025
HK CEO & Director Dealings (28th Feb 2025): Mobvista, Xtep, Onewo, Bonny International
- The data in this insight is collated from the “shareholding disclosure” link on the HKEx website.
- Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors. Or pledging. However, such disclosures are by no means an absolute.
- The key stocks mentioned in this regular series include: Mobvista (1860 HK), Xtep International (1368 HK), Onewo (2602 HK), and Bonny International Holding (1906 HK).
Tencent (700 HK): Expiry-Day Recap; Intra-Day Swing of 4.1%.
- During yesterday’s Option expiration day, Tencent (700 HK) experienced an intra-day swing of 4.1%.
- Trading in the afternoon oscillated around the prominent 500 strike level. Around 66% of calls and 2% of puts expired in the money.
- Volume was lower than in the preceding days; a total of 38 million shares were traded, with the morning session accounting for 53% of the volume.
Asia Real Estate Tracker (28-Feb-2025): HK halts commercial land sales to cure office slump.
- Hong Kong has halted land sales in order to boost the office market within the region.
- Singapore’s Centurion saw their profits more than double to $257M, driven by soaring property valuations.
- Alibaba announces plans to invest a substantial $53 billion in AI infrastructure development.
Monthly Container Shipping Tracker | No, Not All Trade Disruptions Boost Carriers (February 2025)
- Price momentum for deep sea container carriers continued to plunge in January 2025
- January’s revenue decline vs the Summer peak also historically bad despite LNY boost
- We take down emerging consensus view that “all trade disruptions are good for carriers”
China Mobile (941 HK) Pullback Offers a Tactical Re-Entry Opportunity
- In our last insight covering China Mobile (941 HK) we said the stock was overbought. It made a sharp pullback last week that may turn into a good BUY opportunity.
- Support levels to buy range from 79.1 to 76.4, assuming this pullback is a buy-the-dip scenario, something we will discuss in this insight.
- If the stock resumes its rally, the next WEEKLY profit targets will be between 82.64 and 84.4.
Lucror Analytics – Morning Views Asia
- In today’s Morning Views publication we comment on developments of the following high yield issuers: Xiaomi Corp
- In the US, the second estimate for Q4/24 real GDP was unchanged from the advance estimate at an annualised rate of 2.3% q-o-q, driven by a 4.2% increase (unchanged) in consumer spending. That said, the core PCE price index was revised upwards to 2.7% (from 2.5% in the advance estimate).
- Full-year real GDP growth in 2024 stood at 2.8% y-o-y (vs. 2.9% in 2023). Separately, durable goods orders rose 3.1% m-o-m in January (2.0% e / -1.8% p).
BeiGene (6160 HK): Brukinsa Outpaces Competitor in 4Q US Sales; Solid Guidance for 2025
- In 4Q24, BeiGene (6160 HK) reported U.S. sales of Brukinsa of $616M, up 97% YoY and 22% QoQ, with 60%+ of demand growth coming from expanded use in CLL.
- Brukinsa holds 25% market share in new patient starts in the U.S. in CLL, followed by Calquence (20%). For the first time, Brukinsa’s quarterly U.S. revenue outpaced that of Calquence.
- Beigene has guided for 2025 revenue of $4.9–5.3B (up 29–39% YoY), driven by Brukinsa’s U.S. leadership position and continued global expansion in both Europe and other markets.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
